A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Respiratory Medicine

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.rmed.2013.05.004PMID 23768735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.

  2013cited by this paper
• Prophylactic antibiotic therapy for chronic bronchitis.

  2013cited by this paper
• Macrolide effects on the prevention of COPD exacerbations

  2012influential reference
• Azithromycin and the risk of cardiovascular death.

  2012cited by this paper
• Macrolide antibiotics for cystic fibrosis.

  2012cited by this paper
• Azithromycin for prevention of exacerbations of COPD.

  2011influential reference
• Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.

  2010cited by this paper
• Effect of 6 Months of Erythromycin Treatment on Inflammatory Cells in Induced Sputum and Exacerbations in Chronic Obstructive Pulmonary Disease

  2010cited by this paper
• Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy.

  2010cited by this paper
• The pathology of chronic obstructive pulmonary disease.

  2009cited by this paper
• Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.

  2008cited by this paper
• INHIBITORY EFFECTS OF MACROLIDE ANTIBIOTICS ON EXACERBATIONS AND HOSPITALIZATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN JAPAN: A RETROSPECTIVE MULTICENTER ANALYSIS

  2008cited by this paper
• Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations.

  2007cited by this paper
• Increased Macrolide Resistance of Mycoplasma pneumoniae in Pediatric Patients with Community-Acquired Pneumonia

  2007cited by this paper
• Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort.

  2005cited by this paper
• The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD.

  2005cited by this paper
• Macrolide antibiotics for cystic fibrosis.

  2004cited by this paper
• An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages

  2004cited by this paper
• Systemic inflammation in chronic obstructive pulmonary disease

  2003cited by this paper
• Epidemiology of chronic obstructive pulmonary disease.

  2001cited by this paper
• Erythromycin and common cold in COPD.

  2001cited by this paper
• [Prospective, comparative study (1994-1998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD].

  2000cited by this paper
• Epidemiology of chronic obstructive pulmonary disease.

  1990cited by this paper

• Weekly azithromycin for 48 weeks impacts nasopharyngeal microbial prevalence and Streptococcus pneumoniae serotypes in children with HIV-associated chronic lung disease

  2025cites this paper
• Significant Predictors of Azithromycin in Population Pharmacokinetic Analysis: A Systematic Review

  2025cites this paper
• Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines

  2024cites this paper
• Modern view on clinical phenotyping of chronic obstructive pulmonary disease

  2024cites this paper
• Gut Microbiota Modulation in the Management of Chronic Obstructive Pulmonary Disease: A Literature Review

  2024cites this paper
• New concept and algorithm for the management of patients with chronic obstructive pulmonary disease

  2023cites this paper
• Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease

  2022cites this paper
• Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations.

  2021cites this paper
• Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development

  2021cites this paper
• Different Expression of Vitamin D and Vitamin D Receptor Stimulated by Cigarette Smoking

  2021cites this paper
• Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.

  2021cites this paper
• The Deteriorating Patient: Therapies Including Lung Transplantation

  2021cites this paper
• Effectiveness and safety of medicines used in COPD patients

  2020cites this paper
• British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease

  2020cites this paper
• Dementia and Chronic Disease: Management of Comorbid Medical Conditions

  2020influential citation
• Romanian clinical guideline for diagnosis and treatment of COPD

  2020cites this paper
• LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2020cites this paper
• Progress in the mechanism and targeted drug therapy for COPD

  2020cites this paper
• COPD Management in Older Adults with Dementia

  2020cites this paper
• A genome-wide analysis of targets of macrolide antibiotics in mammalian cells

  2020cites this paper
• Effects of long-term macrolide therapy at low doses in stable COPD

  2019cites this paper
• A systematic review and meta-analysis

  2019cites this paper
• In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections

  2019cites this paper
• Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.

  2018cites this paper
• Respiratory simulators in rehabilitation of patients with chronic respiratory diseases

  2018cites this paper
• Antibiotics for exacerbations of chronic obstructive pulmonary disease.

  2018cites this paper
• Should Antibiotic Prophylaxis Be Routinely Used in Patients with Antibody-Mediated Primary Immunodeficiency?

  2018cites this paper
• The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions

  2018cites this paper
• Appropriate antibiotic management of bacterial lower respiratory tract infections

  2018cites this paper
• Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials

  2018cites this paper
• Manejo integral del paciente con exacerbación aguda de la enfermedad pulmonary

  2018cites this paper
• Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis

  2018cites this paper
• The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms

  2018cites this paper
• Recommendations for the pharmacological treatment of COPD: questions and answers

  2017cites this paper
• Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry

  2017cites this paper
• Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma.

  2017cites this paper
• Clinical Update on Nursing Home Medicine: 2017.

  2017cites this paper
• Budesonide, fluticasone propionate, and azithromycin do not modulate the membrane vesicle release by THP-1 macrophages and respiratory pathogens during macrophage infection

  2017cites this paper
• KOAH Alevlenmelerinin Önlenmesinde Farmakolojik Ajanlar

  2017cites this paper
• Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model

  2016cites this paper
• AUTHOR PROOF COPY Not for publication

  2016cites this paper
• Systemic and topical antibiotics for chronic rhinosinusitis.

  2016cites this paper
• Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.

  2016cites this paper
• Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review

  2016cites this paper
• The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

  2016influential citation
• the Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

  2016cites this paper
• Biomarkers for precision medicine in airways disease

  2015cites this paper
• Prophylactic Use of Macrolide Antibiotics for the Prevention of Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis

  2015cites this paper
• Clinical Update on Nursing Home Medicine: 2015.

  2015cites this paper
• ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers.

  2015cites this paper
• Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines

  2015cites this paper
• Tiotropium and its efficacy in the treatment of COPD.

  2015cites this paper
• [Acute exacerbation in COPD and asthma].

  2015cites this paper
• Are prophylactic antibiotics useful in chronic obstructive pulmonary disease?

  2015cites this paper
• Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter?

  2015cites this paper
• [News in the Supportive Care of Chronic Lymphocytic Leukemia].

  2015cites this paper
• Aktuality v podpůrné léčbě chronické lymfocytární leukemie News in the Supportive Care of Chronic Lymphocytic Leukemia

  2015cites this paper
• Long-term antibiotics to reduce COPD exacerbations: pros and cons

  2015cites this paper
• Non-tuberculous mycobacterial lung disease and COPD

  2015cites this paper
• ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers.

  2015cites this paper
• News in the Supportive Care of Chronic Lymphocytic Leukemia

  2015cites this paper
• Justification of the efficacy of antibacterial therapy for the treatment of chronic endometritis

  2015cites this paper
• Personalized medicine in COPD treatment

  2014cites this paper
• Prävention von Exazerbationen

  2014cites this paper
• Immunomodulatory adjuvant therapy in severe community-acquired pneumonia

  2014cites this paper
• Management and prevention of exacerbations of COPD

  2014cites this paper
• The role of macrolides in asthma: current evidence and future directions.

  2014cites this paper
• Macrolide treatment in patients with bronchiectasis: more attention should be paid to the number of exacerbations.

  2014cites this paper
• Chronic obstructive pulmonary disease: getting it right. Does optimal management of chronic obstructive pulmonary disease alter disease progression and improve survival?

  2014cites this paper
• A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Adverse effects of long-term azithromycin use in patients with

  2013cites this paper
• Antibiotic prophylaxis in primary immune deficiency disorders.

  2013cites this paper
• Meta-Analysis of the Adverse Effects of Long-Term Azithromycin Use in Patients with Chronic Lung Diseases

  2013cites this paper